Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · IEX Real-Time Price · USD
2.140
-0.120 (-5.31%)
At close: Jul 2, 2024, 4:00 PM
2.150
+0.010 (0.47%)
After-hours: Jul 2, 2024, 6:32 PM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $150.87 million as of July 2, 2024. Its market cap has decreased by -92.14% in one year.
Market Cap
150.87M
Enterprise Value
-141.19M
1-Year Change
-92.14%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $150.87M, a decrease of -80.73%. That is a compound annual growth rate of -45.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 159.30M | 9.26% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.91% |
| Dec 31, 2021 | 998.90M | 27.59% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 174.48M |
| Abeona Therapeutics | 173.68M |
| Outlook Therapeutics | 172.73M |
| Fennec Pharmaceuticals | 166.94M |
| FibroBiologics | 163.27M |
| Biomea Fusion | 161.75M |
| Achieve Life Sciences | 161.40M |
| P3 Health Partners | 161.08M |